Patents Assigned to EMBRIENT, INC.
  • Publication number: 20250387427
    Abstract: A method of treatment is presented for alleviating and/or repairing damage associated with M1 macrophage driven inflammation through administration of high molecular weight hyaluronic acid (HMW-HA), optionally in combination with platelet-rich plasma (PRP) and/or anti-Stabilin-2 antibodies. Preferred embodiments are formulated for parenteral administration and either directly or indirectly suppress M1 macrophage activity, and/or directly indirectly promote M2 macrophage polarization.
    Type: Application
    Filed: August 27, 2025
    Publication date: December 25, 2025
    Applicant: Embrient, Inc.
    Inventor: Barry E. Rothenberg
  • Publication number: 20250084361
    Abstract: An incubator for cell and tissue culture under controlled atmospheric conditions has a primary air flow control device that forms a primary, preferably laminar flow, air veil across an opening that allows access to the cells or tissue cultures disposed within the incubator. Preferably, most if not all of the air in the primary (laminar flow) air veil is recirculated, and a secondary air flow control device is used that forms a secondary, preferably laminar flow, air veil between the primary (laminar flow) air veil and a user of the incubator.
    Type: Application
    Filed: November 21, 2024
    Publication date: March 13, 2025
    Applicant: Embrient, Inc.
    Inventors: Royal Q. Le, Barry E. Rothenberg, Kyong-su Son
  • Patent number: 12173269
    Abstract: An incubator for cell and tissue culture under controlled atmospheric conditions has a primary air flow control device that forms a primary, preferably laminar flow, air veil across an opening that allows access to the cells or tissue cultures disposed within the incubator. Preferably, most if not all of the air in the primary (laminar flow) air veil is recirculated, and a secondary air flow control device is used that forms a secondary, preferably laminar flow, air veil between the primary (laminar flow) air veil and a user of the incubator.
    Type: Grant
    Filed: March 28, 2023
    Date of Patent: December 24, 2024
    Assignee: Embrient, Inc.
    Inventors: Royal Q. Le, Barry E. Rothenberg, Kyong-su Son
  • Patent number: 11884910
    Abstract: An incubator for cell and tissue culture under controlled atmospheric conditions has a primary air flow control device that forms a primary, preferably laminar flow, air veil across an opening that allows access to the cells or tissue cultures disposed within the incubator. Preferably, most if not all of the air in the primary (laminar flow) air veil is recirculated, and a secondary air flow control device is used that forms a secondary, preferably laminar flow, air veil between the primary (laminar flow) air veil and a user of the incubator.
    Type: Grant
    Filed: August 3, 2023
    Date of Patent: January 30, 2024
    Assignee: Embrient, Inc.
    Inventors: Kyong-su Son, Royal Q. Le, Barry E. Rothenberg
  • Publication number: 20230374437
    Abstract: An incubator for cell and tissue culture under controlled atmospheric conditions has a primary air flow control device that forms a primary, preferably laminar flow, air veil across an opening that allows access to the cells or tissue cultures disposed within the incubator. Preferably, most if not all of the air in the primary (laminar flow) air veil is recirculated, and a secondary air flow control device is used that forms a secondary, preferably laminar flow, air veil between the primary (laminar flow) air veil and a user of the incubator.
    Type: Application
    Filed: August 3, 2023
    Publication date: November 23, 2023
    Applicant: Embrient, Inc.
    Inventors: Kyong-su Son, Royal Q. Le, Barry E. Rothenberg
  • Publication number: 20230242861
    Abstract: An incubator for cell and tissue culture under controlled atmospheric conditions has a primary air flow control device that forms a primary, preferably laminar flow, air veil across an opening that allows access to the cells or tissue cultures disposed within the incubator. Preferably, most if not all of the air in the primary (laminar flow) air veil is recirculated, and a secondary air flow control device is used that forms a secondary, preferably laminar flow, air veil between the primary (laminar flow) air veil and a user of the incubator.
    Type: Application
    Filed: March 28, 2023
    Publication date: August 3, 2023
    Applicant: Embrient, Inc.
    Inventors: Royal Q. Le, Barry E. Rothenberg, Kyong-su Son
  • Patent number: 11634681
    Abstract: An incubator for cell and tissue culture under controlled atmospheric conditions has a primary air flow control device that forms a primary, preferably laminar flow, air veil across an opening that allows access to the cells or tissue cultures disposed within the incubator. Preferably, most if not all of the air in the primary (laminar flow) air veil is recirculated, and a secondary air flow control device is used that forms a secondary, preferably laminar flow, air veil between the primary (laminar flow) air veil and a user of the incubator.
    Type: Grant
    Filed: May 16, 2022
    Date of Patent: April 25, 2023
    Assignee: EMBRIENT, INC.
    Inventors: Royal Q. Le, Barry E. Rothenberg, Kyong-su Son
  • Publication number: 20220275322
    Abstract: An incubator for cell and tissue culture under controlled atmospheric conditions has a primary air flow control device that forms a primary, preferably laminar flow, air veil across an opening that allows access to the cells or tissue cultures disposed within the incubator. Preferably, most if not all of the air in the primary (laminar flow) air veil is recirculated, and a secondary air flow control device is used that forms a secondary, preferably laminar flow, air veil between the primary (laminar flow) air veil and a user of the incubator.
    Type: Application
    Filed: May 16, 2022
    Publication date: September 1, 2022
    Applicant: Embrient, Inc.
    Inventors: Royal Q. Le, Barry E. Rothenberg, Kyong-su Son
  • Patent number: 11365385
    Abstract: An incubator for cell and tissue culture under controlled atmospheric conditions has a primary air flow control device that forms a primary, preferably laminar flow, air veil across an opening that allows access to the cells or tissue cultures disposed within the incubator. Preferably, most if not all of the air in the primary (laminar flow) air veil is recirculated, and a secondary air flow control device is used that forms a secondary, preferably laminar flow, air veil between the primary (laminar flow) air veil and a user of the incubator.
    Type: Grant
    Filed: November 10, 2021
    Date of Patent: June 21, 2022
    Assignee: EMBRIENT, INC.
    Inventors: Royal Q. Le, Barry E. Rothenberg, Kyong-su Son